Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
1.370
-0.090 (-6.16%)
Nov 22, 2024, 4:00 PM EST - Market closed
Salarius Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Cash & Equivalents | 3.27 | 5.9 | 12.11 | 29.21 | 11.12 | 3.74 | Upgrade
|
| Cash & Short-Term Investments | 3.27 | 5.9 | 12.11 | 29.21 | 11.12 | 3.74 | Upgrade
|
| Cash Growth | -71.64% | -51.27% | -58.56% | 162.75% | 197.38% | 15.82% | Upgrade
|
| Receivables | - | - | 1.61 | - | 3.86 | - | Upgrade
|
| Prepaid Expenses | 0.24 | 0.62 | 0.8 | 0.95 | 0.82 | 0.96 | Upgrade
|
| Total Current Assets | 3.51 | 6.52 | 14.52 | 30.16 | 15.8 | 4.69 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | 0.02 | 0.03 | Upgrade
|
| Goodwill | - | - | - | 8.87 | 8.87 | 8.87 | Upgrade
|
| Long-Term Accounts Receivable | - | - | - | 1.61 | - | - | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.07 | 0.13 | 0.19 | 0.25 | 0.31 | Upgrade
|
| Total Assets | 3.55 | 6.59 | 14.65 | 40.83 | 24.93 | 13.89 | Upgrade
|
| Accounts Payable | 0.64 | 0.6 | 2.86 | 1.54 | 1.85 | 1.79 | Upgrade
|
| Accrued Expenses | 0.54 | 0.41 | 1.41 | 0.57 | 0.38 | 0.16 | Upgrade
|
| Short-Term Debt | - | 0.29 | - | - | 0.48 | 0.5 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | - | 0.54 | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.06 | 0.32 | Upgrade
|
| Total Current Liabilities | 1.18 | 1.3 | 4.27 | 2.11 | 2.77 | 3.31 | Upgrade
|
| Total Liabilities | 1.18 | 1.3 | 4.27 | 2.11 | 2.77 | 3.31 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 81.86 | 81.63 | 74.19 | 70.92 | 41.59 | 22.66 | Upgrade
|
| Retained Earnings | -79.49 | -76.35 | -63.81 | -32.2 | -19.43 | -12.08 | Upgrade
|
| Total Common Equity | 2.38 | 5.29 | 10.38 | 38.72 | 22.16 | 10.58 | Upgrade
|
| Shareholders' Equity | 2.38 | 5.29 | 10.38 | 38.72 | 22.16 | 10.58 | Upgrade
|
| Total Liabilities & Equity | 3.55 | 6.59 | 14.65 | 40.83 | 24.93 | 13.89 | Upgrade
|
| Total Debt | - | 0.29 | - | - | 0.48 | 0.5 | Upgrade
|
| Net Cash (Debt) | 3.27 | 5.61 | 12.11 | 29.21 | 10.64 | 3.24 | Upgrade
|
| Net Cash Growth | -71.64% | -53.66% | -58.56% | 174.53% | 228.79% | 0.26% | Upgrade
|
| Net Cash Per Share | 6.29 | 13.75 | 45.59 | 141.25 | 136.62 | 198.04 | Upgrade
|
| Filing Date Shares Outstanding | 1.44 | 0.54 | 0.31 | 0.23 | 0.22 | 0.07 | Upgrade
|
| Total Common Shares Outstanding | 0.64 | 0.49 | 0.28 | 0.23 | 0.12 | 0.02 | Upgrade
|
| Working Capital | 2.34 | 5.22 | 10.25 | 28.05 | 13.02 | 1.38 | Upgrade
|
| Book Value Per Share | 3.70 | 10.74 | 36.83 | 171.18 | 186.14 | 469.53 | Upgrade
|
| Tangible Book Value | 2.38 | 5.29 | 10.38 | 29.86 | 13.29 | 1.71 | Upgrade
|
| Tangible Book Value Per Share | 3.70 | 10.74 | 36.83 | 131.99 | 111.67 | 76.10 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.